Olon Ricerca Bioscience understands the importance of developing safe products for the global population and contributing to the development of efficacious products with an appropriate safety profile. As an outsourcing partner supporting the efforts of our clients to develop new compounds, whether it be a drug candidate, veterinary compound or specialty chemical, Olon Ricerca Bioscience recognizes how fundamental quality is to each step in the process. It is an inherent aspect of our services and is the leading criteria in selection of the right outsourcing partner.
This is a fundamental expectation and core value at Olon Ricerca Bioscience.
Quality management at Olon Ricerca Bioscience is embedded throughout the entire organization. Olon Ricerca Bioscience’s established and well proven quality system, supported by management’s commitment, is the foundation for assuring that materials produced and/or data generated meet the expectations of our clients and the requirements of regulatory agencies. Throughout our business offerings of drug safety assessment and chemical development/manufacture, there is a commitment to the timely delivery of a quality product.
As a part of Olon Group, Olon Ricerca Bioscience can guarantee our clients long-term partnerships that include large-scale manufacturing capabilities in Europe at eight FDA-inspected manufacturing plants.
In addition, access to Olon’s skilled regulatory team, that manage more than 350 DMF’s in more than 70 countries, which has established experience in global regulatory and quality procedures, allows Ricerca Bioscience to support both large pharmaceutical companies seeking specialized services and/or complementary capacities and small and mid-sized pharmaceutical firms that have limited manufacturing infrastructure and rely on CDMOs for a range of services, including regulatory filings, quality assurance, procurement and supply management support.